... to 37 per cent 36.1 per cent due to higher inventory and compliance costs at Caraco as well as lower sales of high-margin products such as Protonix. ...
... including that relating to the generic versions of Neurontin®, Lotrel® and Protonix®, the current economic conditions, competition from brand -name ...
... foaming agents such as Gaviscon, H2 blockers including Tagamet and Pepcid, or Proton-Pump Inhibitors (PPI) such as Prilosec, Protonix, Nexium and Aciphex.
... Lotrel®, Protonix® and Eloxatin®, the current economic conditions, competition from brand-name companies that are under increased pressure to counter ...